Exelixis EXEL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's retained earnings?
- Exelixis (EXEL) reported retained earnings of -$215.79M in Q1 2026.
- How has Exelixis's retained earnings changed year-over-year?
- Exelixis's retained earnings decreased by 32.2% year-over-year, from -$163.29M to -$215.79M.
- What is the long-term trend for Exelixis's retained earnings?
- Over 5 years (2020 to 2025), Exelixis's retained earnings has grown at a -29.7% compound annual growth rate (CAGR), from -$447.57M to -$76.83M.
- What does retained earnings mean?
- The total profits the company has kept and reinvested since it started.
- How do you interpret retained earnings?
- An increase signifies profitable operations and internal growth, while a decrease suggests losses or significant dividend payouts.
- How does retained earnings compare across companies?
- Often negative for R&D-heavy biotech firms that have not yet reached consistent profitability.